Study of Individualized Amonafide to Treat Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00087854
Recruitment Status : Completed
First Posted : July 16, 2004
Last Update Posted : April 23, 2008
Information provided by:
Xanthus Pharmaceuticals, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2005
  Actual Study Completion Date : December 2005